In Brief: Multi-omics Analysis Identifies molecularly defined Alzheimer’s disease subtypes
Beth Israel Lahey HealthInvestigators used machine learning approaches to integrate high-throughput transcriptomic, proteomic, metabolomic, and lipidomic profiles to provide novel critical molecular insights into Alzheimer’s Disease (AD) that single-omic analyses cannot offer.